Alan Jackson’s Final Nashville Concert Helps Raise $2.25 Million for Charcot-Marie-Tooth Disease Research

Alan Jackson closed one of the most remarkable chapters in country music with an emotional farewell performance in Nashville that celebrated his decades-long career while also making a meaningful impact beyond the stage. During his final full-length concert at Nissan Stadium, a portion of ticket proceeds was donated to the Charcot-Marie-Tooth (CMT) Research Foundation, helping support research into the rare neurological disorder that Jackson himself has been living with.

Source: Getty Images

Thanks to fan generosity and matching contributions, the fundraising campaign reached an impressive $2.25 million, providing a significant boost to ongoing efforts to better understand and treat Charcot-Marie-Tooth disease.

Alan Jackson Continues Supporting the CMT Community

Alan Jackson publicly revealed in 2021 that he had been diagnosed with Charcot-Marie-Tooth disease (CMT), a group of inherited genetic disorders that affect the peripheral nerves. The condition gradually damages nerves outside the brain and spinal cord, leading to muscle weakness, balance problems, reduced sensation in the hands and feet, and increasing difficulty with walking and movement.

Although the disease is not considered life-threatening, its progressive nature has made performing increasingly challenging for the Country Music Hall of Fame member.

Throughout his farewell tour, Jackson remained committed to performing for fans while also using his platform to raise awareness about the condition.

A Farewell Concert That Supported Medical Research

Jackson’s final Nashville performance became more than a celebration of his legendary career. Organizers announced that a portion of ticket sales would benefit the Charcot-Marie-Tooth Research Foundation, allowing fans to contribute directly to research simply by attending the event.

@travelwayne Alan Jackson Last Call Concert Outro – Where I Come From !! Amazing Time!! #alanjackson #alanjacksonlastcall #nissanstadium ♬ original sound – TravelWayne

Additional donations from supporters, combined with matching gifts, helped increase the total amount raised to $2.25 million. The funds will help support scientific research aimed at improving treatments and ultimately finding better solutions for people living with Charcot-Marie-Tooth disease.

Why Alan Jackson Chose to Step Away from Touring

After more than four decades of recording hit songs and performing for audiences around the world, Jackson has acknowledged that the physical demands of touring have become increasingly difficult because of CMT.

The disease affects balance, coordination, and muscle strength, making long performances much more challenging than they once were. While Jackson has retired from full-length touring, his decision has consistently been presented as one based on the physical limitations caused by his condition rather than a loss of passion for performing.

Leaving Behind More Than Music

Alan Jackson’s influence extends far beyond his catalog of country classics. His farewell concert demonstrated how a legendary artist can use one final tour to support a cause that has become deeply personal.

By helping raise $2.25 million for Charcot-Marie-Tooth disease research, Jackson turned his final Nashville performance into an opportunity to benefit thousands of families affected by the same rare genetic disorder.

For many fans, the concert was not only a celebration of an extraordinary career but also a reminder that Alan Jackson’s legacy includes compassion, generosity, and a commitment to helping others facing the challenges of Charcot-Marie-Tooth disease.